An interventional study of Morning sunlight in Mental Status Change, sponsored by Efforia, Inc. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-26.
Sponsored by Efforia, Inc · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Sun-Kissed Serenity: Morning Rays for a Brighter Mind is a 30-day dawn rendezvous with nature. Participants are asked to stand outside for 15 minutes each morning, track progress with surveys, and support mental health with natural light.
This remotely administered decentralized trial is designed to meticulously evaluate the impact of daily morning sunlight exposure on mental well-being over a span of 30 days. In an era where society is increasingly fraught with overstimulation and stress, this study seeks to explore a simple, natural intervention that has been both scientifically and anecdotally linked to improved mental health outcomes. Leveraging the NIH Toolbox® Positive Affect Survey and the Personal Feelings Survey, this online study aims to quantify the effects of a 15-minute morning sunlight exposure routine on participants' mood, stress levels, and overall sense of well-being.
The objective behind this innovative approach is to empower individuals to discover the potential mental health benefits of integrating a brief period of sunlight exposure into their daily morning routine. By participating in this trial, individuals are not only taking an active step towards potentially enhancing their own mental wellness but are also contributing valuable data to a broader scientific endeavor aimed at validating a cost-free, accessible method for supporting mental health.
This study will utilize a variety of validated tools to rigorously assess changes in participants' emotional states and personal well-being throughout the trial period. This includes tracking shifts in positive affect, stress levels, and overall mood, to determine whether this straightforward daily practice can yield significant improvements in mental health metrics.
The significance of this study lies in its potential to offer a low-cost, universally accessible intervention for enhancing mental wellness without the need for pharmaceuticals, subscriptions, or the risk of adverse side effects. Despite variables such as weather conditions or individual daily routines, the prospect of establishing a free, evidence-based practice for reducing stress and elevating mood holds considerable promise. Through this remotely conducted trial, the investigators aim to gather conclusive evidence on the efficacy of morning sunlight exposure as a tool for mental health support, thereby contributing to the development of simple, natural strategies for managing stress and improving emotional well-being in today's fast-paced world.
Efforia, Inc is the lead sponsor of 25 studies on the registry; 20 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Single arm where participants act as their own control
Behavioral: Morning sunlight
Participants are asked to get 15 minutes of morning sunlight every day for 30 days.
NIH Toolbox® Item Bank v3.0 - Positive Affect Survey (Ages 18+) Score
This survey assesses your level of positive affect in the past 7 days. Please respond to each question or statement by selecting one option that best describes your feelings or experiences.
Time frame: Change from baseline (Day 1-3) in positive affect scores at 4 weeks after the start of the intervention (Day 28-32)
Personal Feelings Survey
This survey aims to understand your personal feelings, particularly about being alone or feeling isolated. You are asked to indicate how often you feel a certain way.
Time frame: Change from baseline (Day 1-3) in feelings of isolation scores at 4 weeks after the start of the intervention (Day 28-32)
Started Sep 2025 (actual). Primary completion is estimated for Sep 2026, 12 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.